Singapore markets closed

Zhejiang Jingxin Pharmaceutical Co., Ltd. (002020.SZ)

Shenzhen - Shenzhen Delayed price. Currency in CNY
Add to watchlist
11.15-0.04 (-0.36%)
At close: 03:04PM CST
Currency in CNY

Valuation measures4

Market cap (intra-day) 9.63B
Enterprise value 7.83B
Trailing P/E 15.27
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)2.38
Price/book (mrq)1.71
Enterprise value/revenue 1.93
Enterprise value/EBITDA 10.65

Trading information

Stock price history

Beta (5Y monthly) 0.10
52-week change 3-28.45%
S&P500 52-week change 326.94%
52-week high 316.16
52-week low 38.28
50-day moving average 311.15
200-day moving average 311.82

Share statistics

Avg vol (3-month) 312.42M
Avg vol (10-day) 38.31M
Shares outstanding 5861.03M
Implied shares outstanding 6861.03M
Float 8505.15M
% held by insiders 142.29%
% held by institutions 110.56%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 40.3
Forward annual dividend yield 42.65%
Trailing annual dividend rate 30.30
Trailing annual dividend yield 32.68%
5-year average dividend yield 42.88
Payout ratio 440.54%
Dividend date 3N/A
Ex-dividend date 424 May 2024
Last split factor 21.2:1
Last split date 328 May 2021

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 15.59%
Operating margin (ttm)16.84%

Management effectiveness

Return on assets (ttm)4.70%
Return on equity (ttm)11.69%

Income statement

Revenue (ttm)4.1B
Revenue per share (ttm)4.75
Quarterly revenue growth (yoy)10.40%
Gross profit (ttm)N/A
EBITDA 808.92M
Net income avi to common (ttm)638.91M
Diluted EPS (ttm)0.73
Quarterly earnings growth (yoy)13.20%

Balance sheet

Total cash (mrq)2.18B
Total cash per share (mrq)2.53
Total debt (mrq)373.99M
Total debt/equity (mrq)6.54%
Current ratio (mrq)1.63
Book value per share (mrq)6.60

Cash flow statement

Operating cash flow (ttm)947.48M
Levered free cash flow (ttm)472.41M